271 related articles for article (PubMed ID: 23972713)
1. Immune therapy for kidney cancer: a second dawn?
McDermott DF; Atkins MB
Semin Oncol; 2013 Aug; 40(4):492-8. PubMed ID: 23972713
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy for renal cell carcinoma.
Rosenblatt J; McDermott DF
Hematol Oncol Clin North Am; 2011 Aug; 25(4):793-812. PubMed ID: 21763968
[TBL] [Abstract][Full Text] [Related]
3. Immune checkpoint blockade as a novel immunotherapeutic strategy for renal cell carcinoma: a review of clinical trials.
Godwin JL; Zibelman M; Plimack ER; Geynisman DM
Discov Med; 2014 Dec; 18(101):341-50. PubMed ID: 25549705
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy of metastatic renal cell carcinoma.
McDermott DF; Atkins MB
Cancer J; 2008; 14(5):320-4. PubMed ID: 18836337
[TBL] [Abstract][Full Text] [Related]
5. Novel immunotherapeutic strategies in development for renal cell carcinoma.
Inman BA; Harrison MR; George DJ
Eur Urol; 2013 May; 63(5):881-9. PubMed ID: 23084331
[TBL] [Abstract][Full Text] [Related]
6. [Immune anticancer response: recent advances in the treatment of renal cell carcinoma].
Bouet F; Catros V
Ann Biol Clin (Paris); 2004; 62(3):257-68. PubMed ID: 15217758
[TBL] [Abstract][Full Text] [Related]
7. [The present state and the future perspective of immunotherapy of renal cell carcinoma].
Kawashima H
Nihon Rinsho; 2015 Jan; 73(1):167-74. PubMed ID: 25626324
[TBL] [Abstract][Full Text] [Related]
8. Role of cytokine therapy in 2006 and beyond for metastatic renal cell cancer.
Parton M; Gore M; Eisen T
J Clin Oncol; 2006 Dec; 24(35):5584-92. PubMed ID: 17158544
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy for renal cell cancer.
Yang JC; Childs R
J Clin Oncol; 2006 Dec; 24(35):5576-83. PubMed ID: 17158543
[TBL] [Abstract][Full Text] [Related]
10. Immune checkpoint inhibitors as novel targets for renal cell carcinoma therapeutics.
Bailey A; McDermott DF
Cancer J; 2013; 19(4):348-52. PubMed ID: 23867517
[TBL] [Abstract][Full Text] [Related]
11. Renal carcinoma (RC): regulation of antitumoral immune responses.
Heicappell R; Ackermann R
Prog Clin Biol Res; 1992; 378():207-16. PubMed ID: 1284503
[TBL] [Abstract][Full Text] [Related]
12. [Immunotherapy for Renal Cell Carcinoma].
Büchler T
Klin Onkol; 2015; 28 Suppl 4():4S64-8. PubMed ID: 26647891
[TBL] [Abstract][Full Text] [Related]
13. TroVax(®) vaccine therapy for renal cell carcinoma.
Zhang RT; Bines SD; Ruby C; Kaufman HL
Immunotherapy; 2012 Jan; 4(1):27-42. PubMed ID: 22149999
[TBL] [Abstract][Full Text] [Related]
14. Metastatic clear cell renal cell carcinoma: A review of current therapies and novel immunotherapies.
Thomas JS; Kabbinavar F
Crit Rev Oncol Hematol; 2015 Dec; 96(3):527-33. PubMed ID: 26299335
[TBL] [Abstract][Full Text] [Related]
15. Current immunotherapeutic strategies in renal cell carcinoma.
Amato RJ
Surg Oncol Clin N Am; 2007 Oct; 16(4):975-86, xi-xii. PubMed ID: 18022554
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy options in metastatic renal cell cancer: where we are and where we are going.
Passalacqua R; Buti S; Tomasello G; Longarini R; Brighenti M; Dalla Chiesa M
Expert Rev Anticancer Ther; 2006 Oct; 6(10):1459-72. PubMed ID: 17069530
[TBL] [Abstract][Full Text] [Related]
17. Metastatic renal cell cancer treatments.
Sternberg CN
Drugs Today (Barc); 2003; 39 Suppl C():39-59. PubMed ID: 14988745
[TBL] [Abstract][Full Text] [Related]
18. [Immuno-Oncology therapeutic principles in lung and renal cell carcinoma].
Wolf J; Grünwald V
Oncol Res Treat; 2014; 37 Suppl 4():10-3. PubMed ID: 25301191
[No Abstract] [Full Text] [Related]
19. [Immunotherapy of metastatic renal cell cancer].
Manseck A; Wirth M
Urologe A; 1993 Sep; 32(5):360-73. PubMed ID: 7692655
[TBL] [Abstract][Full Text] [Related]
20. [Immunotherapies and targeted therapies in medical oncology].
Rousseau B; Champiat S; Loirat D; Arrondeau J; Lemoine N; Soria JC
Bull Cancer; 2014 Jan; 101(1):31-9. PubMed ID: 24333964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
